* Aspira Women's Health Inc AWH.OQ AWH.O is expected
to show a
rise in quarterly revenue when it reports results on August
14.
* The Austin Texas-based company is expected to report a
35.5% increase in revenue to $2.8 million from $2.07 million a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Aspira Women's
Health Inc
is for a loss of 55 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Aspira
Women's
Health Inc is $4.5, above its last closing price of $3.45.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 -0.75 -0.75 -0.73 Beat 2.7
Dec. 31 2023 -1.05 -0.97 -0.60 Beat 38.5
Sep. 30 2022 -0.98 -0.97 -1.20 Missed -23.1
Jun. 30 2022 -1.05 -1.05 -1.05 Met 0
Mar. -1.20 -1.20 -1.20 Met 0
31 2022
Dec. 31 2021 -1.18 -1.20 -1.20 Met 0
Sep. 30 2021 -1.20 -1.05 -1.35 Missed -28.6
Jun. 30 2021 -0.90 -0.90 -0.90 Met 0
This summary was machine generated August 12 at 02:02 GMT. All
figures in US dollars unless otherwise stated